EdgarLookup
SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company
CytomX Therapeutics, Inc.
Filed
February 14, 2018
Accession Number
0000921895-18-000655
View Document ↗ View on SEC.gov ↗